We subsequently conducted stratified analyses of clinical-serological profiles in SLE patients categorized by post-stimulation STING activation status (HT-DNA-treated PBMCs) to delineate pathophysiological correlations between disease activity markers and STING responsiveness. Here, STING1 is linked to systemic lupus erythematosus.